# Long-term Follow-up of Phase 1 Clinical Trial of CS10BR05(CS10BR05-MSA101)

> **NCT04495582** · — · COMPLETED · sponsor: **Corestemchemon, Inc.** · enrollment: 8 (actual)

## Conditions studied

- Multiple System Atrophy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04495582
- **Lead sponsor:** Corestemchemon, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-28
- **Primary completion:** 2024-09-25
- **Final completion:** 2024-09-25
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04495582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04495582, "Long-term Follow-up of Phase 1 Clinical Trial of CS10BR05(CS10BR05-MSA101)". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT04495582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*